Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update

[GlobeNewswire] – Reports PROCYSBI(R) net product sales of $12.1 million in first quarter 2014 and launch of PROCYSBI(R) in Germany Company to host conference call and webcast today at 4:30 p.m. EDT more

View todays social media effects on RPTP

View the latest stocks trending across Twitter. Click to view dashboard

See who Raptor is hiring next, click here to view